Micro-Immunomagnetic Bead-Anti-Biotin (GMLS-Tag004-microIMB-2.8)

The Micro-Immunomagnetic Bead-Anti-Biotin (2.8 µm) is specialized for specific extraction and reversible recovery directly from complex samples. Driven by enhanced magnetic responsiveness and the mild release characteristics of the anti-biotin system, it locks onto and enriches biotinylated ligands directly in cell culture media or raw serum. Its specially designed antibody layer is completely unhindered by competitive interference from high concentrations of endogenous free biotin in the sample matrix, allowing for the subsequent mild elution of highly pure, fully active target macromolecules.

Key Features
Immune to Matrix Interference: Perfectly overcomes the severe recovery drops seen with traditional Streptavidin beads caused by free biotin competition in cell culture media or serum.
Master of Large-Volume/Complex Samples: The 2.8 µm size generates powerful magnetic attraction, achieving instant magnetic solid-phase separation even in viscous liquids or large-volume samples.
Lossless Native Conformation Recovery: Mild elution conditions completely avoid the destructive effects of extreme pH or denaturing agents on precious samples.

Recommended Applications
Direct capture and recovery of secreted proteins from cell culture supernatants or serum, reversible separation of macromolecular complexes in complex matrices, and late-stage elution in Biopanning workflows.


Order information

Catalog No. Product Name Size Price(In USD)
GMP-SMT-219-Ab01-microIMB-2.8 Micro-Immunomagnetic Bead-Anti-Biotin, 2.8 µm 1 mL
GMP-SMT-219-Ab01-microIMB-2.8 Micro-Immunomagnetic Bead-Anti-Biotin, 2.8 µm 10 mL
GMP-SMT-219-Ab01-microIMB-2.8 Micro-Immunomagnetic Bead-Anti-Biotin, 2.8 µm 100 mL

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

FAQ

Q1: What is the core difference in application between Anti-Biotin monoclonal antibody magnetic beads and Streptavidin magnetic beads?

The fundamental difference lies in the reversibility of the binding and the required elution conditions. Streptavidin Magnetic Beads: Exhibit exceptionally high affinity, resulting in irreversible binding. Elution typically necessitates destructive high-temperature denaturation, making them suitable for assays where target viability is inconsequential, such as nucleic acid detection or NGS targeted capture.

Anti-Biotin Magnetic Beads: Rely on specific antigen-antibody interactions. Their paramount advantage is the capability for gentle, competitive elution utilizing free biotin. This ensures that the recovered target cells (e.g., in immune cell isolation) or target proteins maintain extremely high biological viability and their native conformation.

Q2: When performing positive selection of peripheral blood T cells or NK cells utilizing 2.8 µm Anti-Biotin magnetic beads, how can efficient recovery be achieved?

Capture: Incubate the cells with biotinylated cell-specific monoclonal antibodies (e.g., Biotin-CD3, Biotin-CD56). Subsequently, introduce 2.8 µm Anti-Biotin magnetic beads to facilitate specific binding.

Separation and Elution: Following rapid magnetic washing facilitated by the excellent magnetic responsiveness of the 2.8 µm beads, resuspend the bead-cell complexes in a gentle physiological buffer (e.g., PBS containing 0.5% BSA) supplemented with 2-5 mM free biotin. Incubate at room temperature or 4°C for 10-20 minutes. The free biotin will competitively bind to the antibodies on the magnetic beads, allowing the viable cells to gently dissociate from the bead surface. The high-purity, highly viable cells can then be collected via centrifugation.

Q3: Will Anti-Biotin magnetic beads exhibit significant cross-reactivity with endogenous biotinylated proteins (e.g., intracellular carboxylases) present in biological samples?

The anti-biotin ligands immobilized on the surface of this product are highly specific monoclonal antibodies designed to precisely recognize free biotin domains. When processing intact viable cells or serum/plasma samples, endogenous biotinylated proteins are generally sequestered within cellular mitochondria or exist at exceedingly low concentrations, thereby rarely causing interference. However, when processing severely disrupted whole-cell lysates, to circumvent background interference, it is recommended to pre-block endogenous biotin using a small quantity of free avidin or to employ a high-salt washing protocol.

Q4: How do the 1 µm and 2.8 µm specifications of Anti-Biotin magnetic beads perform in viable cell immunomagnetic sorting and downstream Fluorescence-Activated Cell Sorting (FACS) analysis?

2.8 µm Specification: The size is more commensurate with cell diameters (approximately 7-15 µm), resulting in extremely high magnetic pull efficiency. This makes them particularly well-suited for the rapid, direct isolation of cells from highly complex primary samples such as whole blood or bone marrow. However, due to their larger volume, they may cause scatter interference with the nozzles of certain flow cytometers post-isolation. It is advisable to perform free biotin elution prior to flow cytometric analysis.

1 µm Specification: Exhibits reduced spatial steric hindrance, allowing for a more dense, high-affinity coating of cell surface antigens. This specification is ideal for the capture of subcellular structures (e.g., exosomes, mitochondria) or the micro-enrichment of rare cells. Given their relatively smaller volume, they can occasionally be directly analyzed via FACS while still attached to the cells, negating the necessity for an elution step.

Q5: The surface of Anti-Biotin magnetic beads is conjugated with monoclonal antibodies (IgG). How can one prevent the antibodies themselves from fracturing or shedding during the washing process?

During manufacturing, the IgG is securely anchored to the magnetic bead matrix utilizing directional covalent cross-linking or multi-point cross-linking technologies. Within standard physiological buffers or non-ionic detergents (e.g., 0.1% Tween-20), the antibody structure remains highly stable. Nevertheless, the inclusion of reducing agents (e.g., DTT) in the wash buffer must be strictly avoided, as these agents will disrupt the disulfide bonds of the IgG, leading to the dissociation of the heavy and light chains and their subsequent shedding from the bead surface.


Comments


No comments yet.

Leave a comment